SCHEMBL7684973

SCHEMBL7684973

CCN(c1nc(C)cc(N2CCOCC2)n1)c1ccc(C(C)C)cc1Br

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 18/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7686582 0.89 CRHR1 (0.79) CRHR1
SCHEMBL6986689 0.88 CRHR1 (0.81) CRHR1
SCHEMBL7684537 0.88 CRHR1 (0.79) CRHR1
SCHEMBL6984017 0.86 CRHR1 (0.75) CRHR1
SCHEMBL7687005 0.85 CRHR1 (0.77) CRHR1
SCHEMBL7683418 0.84 CRHR1 (0.73) CRHR1
SCHEMBL7680488 0.84 CRHR1 (0.72) CRHR1
SCHEMBL9046910 0.84 CRHR1 (0.72) CRHR1
SCHEMBL7678011 0.82 CRHR1 (0.81) CRHR1
SCHEMBL7696945 0.82 CRHR1 (0.69) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995010506-A1 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-04-20 WO claimed
US-6342503-B1 ANTIDEPRESSANTS, EATING DISORDERS DUPONT PHARMACEUTICALS COMPANY 2002-01-29 US disclosed
US-6107301-A PSYCHOLOGICAL DISORDERS DUPONT PHARMACEUTICALS COMPANY (US) 2000-08-22 US disclosed
EP-0723533-A1 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-07-31 EP disclosed
WO-1995010506-A1 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-04-20 WO disclosed